TRCT
RXO icon

Tower Research Capital (TRC)’s RXO RXO Stock Holding History

Tower Research Capital (TRC)’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Sell
5,443
-5,707
-51% -$126K ﹤0.01% 1903
2026
Q1 		$163K Buy
11,150
+7,703
+223% +$113K ﹤0.01% 1783
2025
Q4 		$43.6K Buy
3,447
+134
+4% +$1.98K ﹤0.01% 2528
2025
Q3 		$51K Sell
3,313
-17,672
-84% -$285K ﹤0.01% 2518
2025
Q2 		$330K Buy
20,985
+18,591
+777% +$282K 0.01% 1335
2025
Q1 		$45.7K Sell
2,394
-14,995
-86% -$328K ﹤0.01% 2284
2024
Q4 		$415K Buy
17,389
+10,519
+153% +$294K 0.01% 1201
2024
Q3 		$192K Sell
6,870
-10,893
-61% -$308K 0.01% 1659
2024
Q2 		$465K Buy
17,763
+15,288
+618% +$318K 0.01% 1412
2024
Q1 		$54.1K Sell
2,475
-36,424
-94% -$781K ﹤0.01% 2221
2023
Q4 		$905K Buy
38,899
+35,615
+1,085% +$717K 0.01% 919
2023
Q3 		$64.8K Buy
3,284
+1,246
+61% +$24.5K ﹤0.01% 2330
2023
Q2 		$46.2K Sell
2,038
-720
-26% -$14.5K ﹤0.01% 2645
2023
Q1 		$54K Sell
2,758
-43,772
-94% -$840K ﹤0.01% 2423
2022
Q4 		$800K Buy
+46,530
New +$825K 0.03% 470

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Tower Research Capital (TRC)'s RXO Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its RXO (RXO) stake by 51% in Q2 2026, selling an estimated $126K and leaving 5,443 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Tower Research Capital (TRC) first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $905K in Q4 2023. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Tower Research Capital (TRC) held 5,443 shares of RXO worth $150K as of Q2 2026.
  • Tower Research Capital (TRC) sold 5,707 RXO shares in Q2 2026, an estimated $126K.
  • RXO made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1903 holding.
  • Tower Research Capital (TRC) first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s RXO position peaked at $905K in Q4 2023.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.